Sean Bendall, PhD (Damon Runyon-Dale F. Frey Scientist ‘14-‘16, Damon Runyon Fellow ‘09-‘12), of Stanford University, Stanford, and colleagues, reported the development of a new technology that can simultaneously detect as many as 100 clinically important proteins in breast tumor cells-conventional methods can pinpoint only two to four at the same time. This technology, called multiplexed ion beam imaging (MIBI), will enable scientists to provide new insights into cancer cell development that will be valuable for basic research, drug discovery and clinical diagnostics. These results were published in the journal Nature Medicine.
